
An expert analysing a mammogram cancer (Rui Vieira/PA)
(Picture: PA Wire)Around 4,000 women with breast cancer could benefit from a new twice-daily pill approved on the NHS.
The charity Breast Cancer Now has welcomed a decision by the National Institute for Health and Care Excellence to offer abemaciclib which cuts the chance of the disease coming back after tumour removal.